Literature DB >> 17355414

Gastroduodenal injury after radioembolization of hepatic tumors.

Cristina Carretero1, Miguel Munoz-Navas, Maite Betes, Ramon Angos, Jose C Subtil, Ignacio Fernandez-Urien, Susana De la Riva, Josu Sola, Jose I Bilbao, Esther de Luis, Bruno Sangro.   

Abstract

BACKGROUND: Radioembolization is a new tool for the treatment of hepatic tumors that consists in the injection of biocompatible microspheres carrying radioisotopes into the hepatic artery or its branches.
METHODS: We have performed radioembolization in 78 patients with hepatic tumors using resin-based microspheres loaded with yttrium-90. All patients were previously evaluated to minimize the risk of hazardous irradiation to nontarget organs and to obtain the data needed for dose calculation.
RESULTS: We report a complication found in three cases (3.8%) that consists of abdominal pain resulting from gastroduodenal lesions and that had a chronic, insidious course. Microscopically, microspheres were detected in the specimens obtained from all affected gastric areas. Since these gastroduodenal lesions do not appear when nonradiating microspheres are injected in animals, lesions are likely to be due to radiation and not to an ischemic effect of vascular occlusion by spheres.
CONCLUSIONS: We believe that a pretreatment evaluation that includes a more thorough scrutiny of the hepatic vascularization in search of small collaterals connecting to the gastroduodenal tract can help prevent this awkward complication.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17355414     DOI: 10.1111/j.1572-0241.2007.01172.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  35 in total

Review 1.  Radioembolization for primary and metastatic liver cancer.

Authors:  Khairuddin Memon; Robert J Lewandowski; Laura Kulik; Ahsun Riaz; Mary F Mulcahy; Riad Salem
Journal:  Semin Radiat Oncol       Date:  2011-10       Impact factor: 5.934

2.  Hepatic radioembolization complicated by gastrointestinal ulceration.

Authors:  Jeremy Collins; Riad Salem
Journal:  Semin Intervent Radiol       Date:  2011-06       Impact factor: 1.513

Review 3.  Chemoembolization and radioembolization for metastatic disease to the liver: available data and future studies.

Authors:  Khairuddin Memon; Robert J Lewandowski; Ahsun Riaz; Riad Salem
Journal:  Curr Treat Options Oncol       Date:  2012-09

4.  Is prophylactic embolization of the hepatic falciform artery needed before radioembolization in patients with 99mTc-MAA accumulation in the anterior abdominal wall?

Authors:  Hojjat Ahmadzadehfar; Markus Möhlenbruch; Amir Sabet; Carsten Meyer; Marianne Muckle; Torjan Haslerud; Kai Wilhelm; Hans Heinz Schild; Hans Jürgen Biersack; Samer Ezziddin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-04-15       Impact factor: 9.236

Review 5.  Radioembolization of hepatic tumors.

Authors:  Andrew Kennedy
Journal:  J Gastrointest Oncol       Date:  2014-06

Review 6.  Treatment response assessment following transarterial radioembolization for hepatocellular carcinoma.

Authors:  Zersenay Alem; Timothy E Murray; Csilla Egri; John Chung; David Liu; Khaled M Elsayes; Silvia D Chang; Alison Harris
Journal:  Abdom Radiol (NY)       Date:  2021-04-28

Review 7.  SIR-Spheres yttrium-90 radioembolization for the treatment of unresectable liver cancers.

Authors:  Rita Golfieri
Journal:  Hepat Oncol       Date:  2014-09-09

Review 8.  Advances in managing hepatocellular carcinoma.

Authors:  Marielle Reataza; David K Imagawa
Journal:  Front Med       Date:  2014-05-08       Impact factor: 4.592

9.  Yttrium-90 microsphere radioembolization for the treatment of liver malignancies: a structured meta-analysis.

Authors:  M A D Vente; M Wondergem; I van der Tweel; M A A J van den Bosch; B A Zonnenberg; M G E H Lam; A D van Het Schip; J F W Nijsen
Journal:  Eur Radiol       Date:  2008-11-07       Impact factor: 5.315

Review 10.  Radioembolization for the treatment of unresectable hepatocellular carcinoma: a clinical review.

Authors:  Saad-M Ibrahim; Robert-J Lewandowski; Kent-T Sato; Vanessa-L Gates; Laura Kulik; Mary-F Mulcahy; Robert-K Ryu; Reed-A Omary; Riad Salem
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.